Patents by Inventor Elliot Parker TAGUE

Elliot Parker TAGUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF
    Publication number: 20230241026
    Abstract: The technology described herein is directed to polypeptide systems using drug-controlled peptide docking domains and cognate docking domain-binding peptides and their use to control cellular signaling, activity, and/or gene expression.
    Type: Application
    Filed: February 23, 2023
    Publication date: August 3, 2023
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: John T. NGO, Mary DUNLOP, Elliot Parker TAGUE, Nathan Michael TAGUE, Alexander Michael MARZILLI
  • Drug-controlled systems and uses thereof
    Patent number: 11660288
    Abstract: The technology described herein is directed to polypeptide systems using drug-controlled peptide docking domains and cognate docking domain-binding peptides and their use to control cellular signaling, activity, and/or gene expression.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: May 30, 2023
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: John T. Ngo, Mary Dunlop, Elliot Parker Tague, Nathan Michael Tague, Alexander Michael Marzilli
  • ENGINEERED EXTRACELLULAR RECEPTOR CONSTRUCTS AND USES THEREOF
    Publication number: 20220064252
    Abstract: Described herein are methods and compositions related to modular engineered receptor polypeptide constructs and their use in modulating the activity of a cell.
    Type: Application
    Filed: August 27, 2021
    Publication date: March 3, 2022
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Elliot Parker TAGUE, John T. NGO, Jeffrey Blye MCMAHAN
  • NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF
    Publication number: 20220062234
    Abstract: The technology described herein is directed to polypeptide systems using drug-controlled peptide docking domains and cognate docking domain-binding peptides and their use to control cellular signaling, activity, and/or gene expression.
    Type: Application
    Filed: August 31, 2021
    Publication date: March 3, 2022
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: John T. NGO, Mary DUNLOP, Elliot Parker TAGUE, Nathan Michael TAGUE, Alexander Michael MARZILLI